SavedAdd your journal

Journals / Klimik Dergisi / 2011 / Cilt: 24 - Sayı: 1

Seroprevalance of HBsAg and Anti-HCV and their correlation to Age and gender in blood donors in the province of Konya

Konya ilinde kan donörlerinde HBsAg ve Anti-HCV seroprevalansı ve yaş ve cinsiyetle ilişkisi

Hale TURAN
Gülhan ÜNLER KANAT
Kıvanç ŞEREFHANOĞLU
Hande ARSLAN
Pages
36–39
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: It was observed that, while there was a decrease in the seropositivity of HBV, the seropositivity of anti-HCV was similar to the results of other studies in our country.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, the records of 17 071 donors applying to Başkent University Konya Hospital Blood Center between June 2003 and June 2009 were evaluated retrospectively to determine the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections.
📊
Key Findings & Data:Results: HBsAg and anti-HCV were positive in 262 (1.53%) and 84 (0.5%) donors, respectively.
💡
Conclusion & Impact:Conclusions: It was observed that, while there was a decrease in the seropositivity of HBV, the seropositivity of anti-HCV was similar to the results of other studies in our country.
🔬Design:Research Article
📍Scope:2003 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, the records of 17 071 donors applying to Başkent University Konya Hospital Blood Center between June 2003 and June 2009 were evaluated retrospectively to determine the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. Methods: The blood samples were tested for HBsAg and anti- HCV by chemiluminescent microparticle immunoassay (CMIA). Results: HBsAg and anti-HCV were positive in 262 (1.53%) and 84 (0.5%) donors, respectively. There was no significant difference in terms of age and gender. Conclusions: It was observed that, while there was a decrease in the seropositivity of HBV, the seropositivity of anti-HCV was similar to the results of other studies in our country.

Özet

Amaç: Kan donörlerinde hepatit B virusu (HBV) ve hepatit C virusu (HCV) infeksiyonlarının sıklığını araştırmak amacıyla, Haziran 2003-Haziran 2009 tarihleri arasında Başkent Üniversitesi Konya Uygulama ve Araştırma Merkezi Hastanesi Kan Merkezine başvuran 17 071 donörün kayıtları geriye dönük incelendi. Yöntemler: Donörlerin HBV ve HCV seropozitifliği kemilümine -san mikropartikül immünoessey (CMIA) yöntemiyle araştırıldı. Bulgular: HBsAg seropozitifliği, örneklerin 262 (%1.53)sinde, anti-HCV 84 (%0.5)ünde saptandı. Yaş ve cinsiyete göre anlamlı fark tespit edilmedi. Sonuçlar: Yıllar içinde HBV seropozitifliğinde bir azalma tespit edilirken, anti-HCV seropozitifliğinin ülkemizdeki diğer çalışma sonuçlarıyla benzer olduğu görüldü.

🔖

Cite This Article

TURAN, H., KANAT, G. Ü., ŞEREFHANOĞLU, K., ARSLAN, H. (2022). Seroprevalance of HBsAg and Anti-HCV and their correlation to Age and gender in blood donors in the province of Konya. Klimik Dergisi, Cilt: 24 - Sayı: 1, 36–39. https://ajindex.com/articles/573662

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Medical Officers of the Ministry of Health. Memorandum: homologous serum jaundice. Lancet. 1943
  2. 241(6229): 83-8. [Crossref] 2.Koziel MJ, Siddiqui A. Hepatitis B virus and hepatitis D virus. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 6th ed. New York: Churchill Livingstone, 2005: 1864-90. 3.Dilek İ, Demir C, Bay A, Akdeniz H, Öner AF. Seropositivity rates of HBsAg, anti-HCV, anti-HIV and VDRL blood donors in Eastern Turkey. Turk J Hematol. 2007
  3. 24(1): 4-7. 4.Sağlık İstatistikleri Yıllığı 2008. Bölüm 3 [İnternet]. Ankara: T.C. Sağlık Bakanlığı [erişim 5 Aralık 2010]. http://www.saglik.gov.tr/ TR/Genel/BelgeGoster.aspx?F6E10F8892433CFFF88F742D0D711 251F98E2B0DB37EDA76. 5.Hepatitis B [İnternet]. Geneva: World Health Organization, Department of Communicable Diseases Surveillance and Response [erişim 5 Aralık 2010]. http://www.who.int/csr/disease/hepatitis/ HepatitisB_whocdscsrlyo2002_2.pdf. 6.Kocak N, Hepgul S, Ozbayburtlu S, et al. Trends in major transfusion-transmissible infections among blood donors over 17 years in Istanbul, Turkey. J Int Med Res. 2004
  4. 32(6): 671-5. 7.Mıstık R. Türkiyede viral hepatit epidemiyolojisi - yayınların irdelenmesi. In: Tabak F, Balık İ, Tekeli E, eds. Viral Hepatit 2007. Ankara: Viral Hepatitle Savaşım Derneği, 2007: 10-50. 8.Thomas DL, Ray SC, Lemon SM. Hepatitis C. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 6th ed. New York: Churchill Livingstone, 2005: 1950-81. 9.Emekdaş G, Cavuşlu S, Öncül O, Artuk Ç, Aksoy A. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol. 2006
  5. 21(4): 299-305. 10.Kaya S. Kan donörlerinde hepatitis B virusu, hepatit C virusu ve insan immun yetmezlik virusu infeksiyonu ve sifilis sıklığı. Klimik Derg. 2008
  6. 21(2): 65-8. 11.Ağuş N, Özkalay Yılmaz N, Cengiz A, Şanal E, Sert H. Kan donörlerinde HBsAg, anti-HCV, anti-HIV seroprevalansı. Ankem Derg. 2008
  7. 22(1): 7-9. 12.Temiz H, Gül K. Kan vericilerinin HBsAg, anti-HCV, anti-HIV ve VDRL test sonuçlarının değerlendirilmesi. İnfeks Derg. 2008
  8. 22(2): 79-82. 13.Öksüz Ş, Yıldırım M, Özaydın Ç, Şahin İ, Şencan İ. Düzce bölgesi kan vericilerinde HBsAg, anti-HCV ve anti-HIV seroprevalansı. Viral Hepatit Derg. 2008
  9. 13(1): 27-30. 14.Şahin D, Şahin İ, Sözeri F, Önder K. Kırklareli Devlet Hastanesi Kan Merkezine başvuran donörlerde HBV, HCV ve HIV seroprev